Article

Key challenges and ways forward in researching the "good death": qualitative in-depth interview and focus group study.

Primary Palliative Care Research Group, Division of Community Health Sciences: General Practice Section, University of Edinburgh, EH8 9DX.
BMJ (Clinical research ed.) 04/2007; 334(7592):521. DOI:10.1136/bmj.39097.582639.55 pp.521
Source: PubMed

ABSTRACT To understand key challenges in researching end of life issues and identify ways of overcoming these.
Qualitative study involving in-depth interviews with researchers and focus groups with people affected by cancer.
An international sample of 32 researchers; seven patients with experience of cancer; and four carers in south east Scotland.
Researchers highlighted the difficulty of defining the end of life, overprotective gatekeeping by ethics committees and clinical staff, the need to factor in high attrition rates associated with deterioration or death, and managing the emotions of participants and research staff. People affected by cancer and researchers suggested that many people nearing the end of life do want to be offered the chance to participate in research, provided it is conducted sensitively. Although such research can be demanding, most researchers believed it to be no more problematic than many other areas of research and that the challenges identified can be overcome.
The continuing taboos around death and dying act as barriers to the commissioning and conduct of end of life research. Some people facing death, however, may want to participate in research and should be allowed to do so. Ethics committees and clinical staff must balance understandable concern about non-maleficence with the right of people with advanced illness to participate in research. Despite the inherent difficulties, end of life research can be conducted with ethical and methodological rigour. Adequate psychological support must be provided for participants, researchers, and transcribers.

0 0
 · 
0 Bookmarks
 · 
37 Views
  • Source
    Article: The feasibility of a single-blinded fast-track pragmatic randomised controlled trial of a complex intervention for breathlessness in advanced disease.
    [show abstract] [hide abstract]
    ABSTRACT: The Breathlessness Intervention Service is a novel service for patients with intractable breathlessness regardless of aetiology. It is being evaluated using the Medical Research Council's framework for the evaluation of complex interventions. This paper describes the feasibility results of Phase II: a single-blinded fast-track pragmatic randomised controlled trial. A single-blinded fast-track pragmatic randomised controlled trial was conducted for patients with chronic obstructive pulmonary disease referred to the service. Patients were randomised to either receive the intervention immediately for an eight-week period, or receive the intervention after an eight-week period on a waiting list during which time they received standard care. Outcomes examined included: response rates to the trial; response rates to the individual questionnaires and items; comments relating to the trial functioning made during interviews with patients, carers, referrers and service providers; and, researcher fieldwork notes. 16 of the 20 eligible patients agreed to participate in a recruitment visit (16/20); 14 respondents went on to complete a recruitment visit/baseline interview. The majority of those who completed a recruitment visit/baseline interview completed the RCT protocol (13/14); 12 of their carers were recruited and completed the protocol. An unblinding rate of 6/25 respondents (patients and carers) was identified. Missing data were minimal and only one patient was lost to follow up. The fast-track trial methodology proved feasible and acceptable. Two of the baseline/outcome measures proved unsuitable: the WHO performance scale and the Schedule for the Evaluation of Individual Quality of Life-Direct Weighting (SEIQoL-DW). This study adds to the evidence that fast-track randomised controlled trials are feasible and acceptable in evaluations of palliative care interventions for patients with non-malignant conditions. Reasonable response rates and low attrition rates were achieved. Further, with adequate preparation of the research and randomisation teams, clinicians, and responders, and effective liaison with the clinicians, single-blinding proved possible. Methods were identified to reduce unblinding through careful attention to the type of data collected at unblinded measurement points; the content of interviews should be carefully considered when designing blinded-trial protocols. Clinical Trials.gov NCT00711438.
    BMC Palliative Care 08/2009; 8:9. · 1.12 Impact Factor

Full-text

View
6 Downloads
Available from
12 Nov 2012

Keywords

32 researchers
 
Adequate psychological support
 
attrition rates
 
barriers
 
clinical staff
 
commissioning
 
continuing taboos
 
Ethics committees
 
focus groups
 
inherent difficulties
 
international sample
 
key challenges
 
life issues
 
life research
 
overprotective gatekeeping
 
Qualitative study
 
research staff
 
Researchers
 
researching end
 
south east Scotland